Uwell Biopharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	220.31	43.4	23.09	27.71	49.76	35.69
Short-Term Investments	-	4.5	63	-	18	-
Cash & Short-Term Investments	220.31	47.9	86.09	27.71	67.76	35.69
Cash Growth	695.07%	-44.37%	210.70%	-59.11%	89.86%	-62.25%
Other Receivables	0.03	0.04	0.07	0	0.02	0.82
Receivables	0.03	0.04	0.07	0	0.02	0.82
Prepaid Expenses	0.44	0.46	0.71	0.48	4.32	2.94
Other Current Assets	0.02	0.09	0.05	0.27	0.06	0.18
Total Current Assets	220.79	48.48	86.91	28.46	72.16	39.63
Property, Plant & Equipment	16.73	19.56	25.48	26.6	33.11	38.92
Other Intangible Assets	0.02	0.04	0.09	0.23	0.43	0.42
Other Long-Term Assets	8.19	8.08	6.04	5.11	0.58	0.58
Total Assets	245.73	76.16	118.51	60.4	106.27	79.55
Accrued Expenses	12.09	5.36	4.42	5.62	5.52	4.45
Current Portion of Leases	2.57	4.25	4.14	3.4	4.19	4.04
Other Current Liabilities	0.95	1.09	0.49	0.8	1.09	1.44
Total Current Liabilities	15.61	10.7	9.05	9.81	10.8	9.93
Long-Term Leases	-	0.86	3.98	4.95	8.34	12.48
Total Liabilities	15.61	11.56	13.03	14.76	19.15	22.42
Common Stock	117	117	117	57	251.8	171.8
Additional Paid-In Capital	153.08	2.54	47.54	2.54	3.18	3.18
Retained Earnings	-90.3	-55.3	-59.43	-14.26	-168.23	-118.23
Comprehensive Income & Other	50.35	0.38	0.38	0.37	0.37	0.38
Shareholders' Equity	230.13	64.61	105.48	45.64	87.13	57.13
Total Liabilities & Equity	245.73	76.16	118.51	60.4	106.27	79.55
Total Debt	2.57	5.11	8.12	8.34	12.53	16.53
Net Cash (Debt)	217.73	42.79	77.98	19.37	55.23	19.16
Net Cash Growth	1024.36%	-45.13%	302.67%	-64.94%	188.23%	-78.99%
Net Cash Per Share	1.86	0.37	0.88	0.34	2.34	0.90
Filing Date Shares Outstanding	117	117	117	57	29.2	21.2
Total Common Shares Outstanding	117	117	117	57	29.2	21.2
Working Capital	205.18	37.79	77.86	18.65	61.36	29.69
Book Value Per Share	1.97	0.55	0.90	0.80	2.98	2.69
Tangible Book Value	230.1	64.57	105.4	45.41	86.7	56.71
Tangible Book Value Per Share	1.97	0.55	0.90	0.80	2.97	2.67
Machinery	16.44	16.44	16.44	14.44	14.31	14.03
Construction In Progress	1.11	-	-	-	5.79	5.79
Leasehold Improvements	9.32	9.32	9.32	9.32	3.19	3.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.